Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 30 Oct 2025

Validating wearable step counts in multiple sclerosis research: a replication study

in Multiple Sclerosis and Neuroimmunology

Myla D. Goldman
Shanshan Chen
Bhavana Kunisetty
Jeffrey M. Gelfand
Bruce A. C. Cree
Valerie J. Block

Frontiers in Neurology

doi 10.3389/fneur.2025.1709389

304 views

Original Research

Published on 29 Oct 2025

A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany

in Multiple Sclerosis and Neuroimmunology

Achim Berthele
Clemens Gödel
Boris-Alexander Kallmann
Markus Kowarik
Klaus Lehmann-Horn
Martin Marziniak
Sebastian Rauer
Veit Rothhammer
Florian Then Bergh
Mathias Wahl

Frontiers in Neurology

doi 10.3389/fneur.2025.1674742

355 views

Original Research

Published on 27 Oct 2025

Factors influencing health behavior changes in people with early multiple sclerosis: process evaluation of the multicenter randomized controlled POWER@MS1 trial

in Multiple Sclerosis and Neuroimmunology

Barbara von Glasenapp
Nicole Krause
Carlotta Derad
Karin Riemann-Lorenz
Björn Meyer
Markus van de Loo
Herbert Temmes
Stefan Gold
Christoph Heesen

Frontiers in Neurology

doi 10.3389/fneur.2025.1635872

913 views

Systematic Review

Published on 23 Oct 2025

Effectiveness of respiratory muscle training in adults with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Yuping Xiang
Oufeng Tang
Ling Zeng

Frontiers in Neurology

doi 10.3389/fneur.2025.1665651

363 views

Original Research

Published on 23 Oct 2025

The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Qingli Sun
Xinran Ma
Linjing Zhang
Danyang Tian

Frontiers in Neurology

doi 10.3389/fneur.2025.1598885

405 views

Original Research

Accepted on 22 Oct 2025

Effect of Hyperbaric Oxygen Therapy on Peripheral Blood Inflammatory Markers in Patients with Neuromyelitis Optica Spectrum Disorder: A Retrospective Cohort Study

in Multiple Sclerosis and Neuroimmunology

Liya Pan
Yanming Mo
Yulan Wei
Shisheng Luo
Yuan Wu

Frontiers in Neurology

461 views

Original Research

Accepted on 20 Oct 2025

Effects of eculizumab and rituximab on visual function, motor function and social quality in patients with NMOSD: A comparative study

in Multiple Sclerosis and Neuroimmunology

Yihan Liu
Li Meng
Jiyuan Li
Xiao Wang
Xiaoman Zhang
Xiangzeng Kong
Yongzhi Zhang

Frontiers in Neurology

229 views

Original Research

Published on 17 Oct 2025

Comparison between primary and secondary central nervous system vasculitis in terms of clinical, biochemical, radiological, histopathological features, and outcomes: a single-center retrospective cohort study

in Multiple Sclerosis and Neuroimmunology

Pasquale Scoppettuolo
Lucie Pothen
Aline van Maanen
Valeria Onofrj
Selda Aydin
Olivier Gheysens
Renaud Lhommel
André Peeters
Vincent van Pesch
Halil Yildiz

Frontiers in Neurology

doi 10.3389/fneur.2025.1602427

1,938 views

Opinion

Published on 15 Oct 2025

Dyadic sleep in people with multiple sclerosis and their partners: current research and future directions

in Multiple Sclerosis and Neuroimmunology

Anna Zanotto
Catherine F. Siengsukon

Frontiers in Neurology

doi 10.3389/fneur.2025.1682411

552 views

Review

Published on 13 Oct 2025

Treatment and prognosis of failure of first-line immunotherapy or recurrent autoimmune encephalitis patients with ofatumumab—a fully human anti-CD20 mAb

in Multiple Sclerosis and Neuroimmunology

Yajing Liu
Yanbo Zhang
Zhijiao Song
Shuanghao Feng
Tongxin Cao
Hui Bu

Frontiers in Neurology

doi 10.3389/fneur.2025.1671481

635 views

Systematic Review

Published on 10 Oct 2025

Effects of non-invasive brain stimulation on balance control in patients with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Longtao Zhang
Yanxiao Sun
Zhihao Diao
Yifan Jiang
Yufei Hu
Yuxia Ma

Frontiers in Neurology

doi 10.3389/fneur.2025.1696343

1,356 views

Original Research

Published on 09 Oct 2025

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study

in Multiple Sclerosis and Neuroimmunology

Gytis Makarevičius
Rasa Kizlaitienė
Gintaras Kaubrys
Nataša Giedraitienė

Frontiers in Neurology

doi 10.3389/fneur.2025.1635618

1,184 views

Systematic Review

Published on 07 Oct 2025

Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis

in Multiple Sclerosis and Neuroimmunology

Zhuyuan Fan
Dan Liu
Guangwei Zhang
Xinlin Guo

Frontiers in Neurology

doi 10.3389/fneur.2025.1649429

1,488 views

Original Research

Published on 02 Oct 2025

The frequency of psoriasis in Australian multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Varitsara Mangkorntongsakul
Ariadna Fontes-Villalba
Turlough Montague
Olivia Charlton
Chun-Ting Justin Kwong
Helen Marie McGuire
Venkatesha Venkatesha
Geoffrey Herkes
Saxon Smith
John Parratt

Frontiers in Neurology

doi 10.3389/fneur.2025.1663015

1,466 views

Original Research

Accepted on 30 Sep 2025

Does C1 Esterase Inhibitor Play a Role in Post COVID-19 Neurological Symptoms? A Randomized, Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study

in Multiple Sclerosis and Neuroimmunology

Isaac R. Melamed
Caley Buckley
Mary Ellen Bayko
Joe Lynn Williams
Noga Orr (Or-Geva), PhD

Frontiers in Neurology

207 views

Editorial

Published on 30 Sep 2025

Editorial: Women in multiple sclerosis and neuroimmunology: from bench to bedside

in Multiple Sclerosis and Neuroimmunology

Jessy J. Alexander
Krista D. DiSano
Liliana Patrucco
Mireya Fernandez-Fournier

Frontiers in Neurology

doi 10.3389/fneur.2025.1677618

1,279 views